ADARB1 and mesothelioma: This was consistent with the observed upregulation of Yes‐associated protein and Transcriptional co‐activator with PDZ‐binding motif (YAP/TAZ) pathway [15] alongside decrease in ADAR2 expression upon blocking the YAP/TAZ pathway in mesothelioma cells [17].